THRL — Target Healthcare Reit Income Statement
0.000.00%
- £615.90m
- £823.96m
- £69.55m
- 87
- 65
- 98
- 98
Annual income statement for Target Healthcare Reit, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 44.3 | 50 | 63.9 | 67.7 | 69.6 |
Cost of Revenue | |||||
Gross Profit | 44.2 | 49.9 | 63.7 | 67.6 | 69.4 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.37 | 1.29 | 8.16 | 64.2 | -15.1 |
Operating Profit | 35.9 | 48.7 | 55.7 | 3.56 | 84.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 31.6 | 43.9 | 49.1 | -6.57 | 73 |
Provision for Income Taxes | |||||
Net Income After Taxes | 31.6 | 43.9 | 49.1 | -6.57 | 73 |
Net Income Before Extraordinary Items | |||||
Net Income | 31.6 | 43.9 | 49.1 | -6.57 | 73 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 31.6 | 43.9 | 49.1 | -6.57 | 73 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.074 | 0.094 | 0.082 | -0.01 | 0.118 |
Dividends per Share |